Bay Area Biopharma Company Uses ALS to Tackle Sickle Cell Disease
The protein crystallography capabilities at the Advanced Light Source’s (ALS’s) Beamline 8.3.1 have been critical to Global Blood Therapeutics’ (GBT’s) ongoing effort to formulate a better treatment for sickle cell disease (SCD).
More »